IM Cannabis (IMCC) Intangibles (2019 - 2026)
IM Cannabis' (IMCC) quarterly Intangibles came in at $562946.8 in Q1 2026, down 73.18% year-on-year from $2.1 million in Q1 2025, and down 35.76% quarter-over-quarter from $876279.4 in Q4 2025.
IM Cannabis (IMCC) Intangibles (2019 - 2026) Analysis & Trends
IM Cannabis' Intangibles history runs 8 years deep, the most recent figure standing at $562946.8 for Q1 2026.
- On a quarterly basis, Intangibles fell 73.18% year-over-year to $562946.8 in Q1 2026; TTM through Mar 2026 was $562946.8, a 73.18% decrease from a year earlier, with the FY2025 full-year figure at $876279.4, down 64.0% from the prior year.
- Intangibles slipped to $562946.8 in Q1 2026 per IMCC's latest filing, from $876279.4 in the prior quarter.
- Across five years, Intangibles topped out at $23.2 million in Q1 2022 and bottomed at $562946.8 in Q1 2026.
- The 5-year median for Intangibles is $4.0 million (2024), against an average of $5.4 million.
- Biggest YoY gain for Intangibles was 294.11% in 2022; the steepest drop was 79.85% in 2022.
- Year by year, Intangibles stood at $5.8 million in 2022, then slipped by 26.85% to $4.3 million in 2023, then slumped by 44.03% to $2.4 million in 2024, then slumped by 63.27% to $876279.4 in 2025, then tumbled by 35.76% to $562946.8 in 2026.
- Per Business Quant, the three latest IMCC Intangibles figures stand at $562946.8 (Q1 2026), $876279.4 (Q4 2025), and $1.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | 562,946.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 562,946.79 |
| Dec 31, 2025 | 876,279.44 |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 2.39 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 2.69 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Dec 31, 2023 | 4.26 Mn |
| Sep 30, 2023 | 4.49 Mn |
| Jun 30, 2023 | 4.89 Mn |
| Mar 31, 2023 | 5.44 Mn |
| Dec 31, 2022 | 5.83 Mn |
| Sep 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 20.96 Mn |
| Mar 31, 2022 | 23.24 Mn |
| Dec 31, 2021 | 18.12 Mn |
| Sep 30, 2021 | 22.74 Mn |
| Jun 30, 2021 | 6.52 Mn |